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The objective of this study was to compare in-hospital deaths and
length of stays for diabetes-related preventable hospitalizations
(D-RPHs) in Hawai‘i for Asian American, Pacific Islander, and
white Medicare recipients aged 65 years or older.
Methods
We considered all hospitalizations of older (>65 years) Japanese,
Chinese, Native Hawaiians, Filipinos, and whites living in Hawai‘i
with  Medicare  as  the  primary  insurer  from  December  2006
through December 2010 (n = 127,079).  We used International
Classification of Diseases – 9th Revision (ICD-9) codes to identi-
fy D-RPHs as defined by the Agency for Healthcare Research and
Quality. Length of stays and deaths during hospitalization were
compared for Asian American and Pacific Islander versus whites
in multivariable regression models, adjusting for age, sex, loca-
tion of residence (Oahu, y/n), and comorbidity.
Results
Among the group studied, 1,700 hospitalizations of 1,424 patients
were D-RPHs. Native Hawaiians were significantly more likely to
die during a D-RPH (odds ratio [OR], 3.92; 95% confidence inter-
val [CI], 1.42–10.87) than whites. Filipinos had a significantly
shorter length of stay (relative risk [RR], 0.77; 95% CI, 0.62–0.95)
for D-RPH than whites. Among Native Hawaiians with a D-RPH,
59% were in the youngest age group (65–75 y) whereas only 6.3%
were in the oldest (≥85 y). By contrast, 23.2% of Japanese were in
the youngest age group, and 32.2% were in the oldest.
Conclusion
This statewide study found significant differences in the clinical
characteristics and outcomes of D-RPHs for Asian American and
Pacific Islanders in Hawai‘i. Native Hawaiians were more likely to
die during a D-RPH and were hospitalized at a younger age for a
D-RPH than other studied racial/ethnic groups. Focused interven-
tions targeting Native Hawaiians are needed to avoid these out-
comes.
Introduction
Diabetes rates are higher among many Asian American and Pa-
cific Islander populations than among whites (1). Native Hawaii-
ans have some of the highest diabetes rates in the world (2,3). Dia-
betes risk increases considerably with age. Medicare covers most
diabetes care for participants aged 65 years and older. The Asian
American and Pacific Islander population in the United States is
approximately 12 million and is increasing rapidly (4); therefore,
the numbers of Medicare beneficiaries who are Asian Americans
or Pacific Islanders are likely to grow faster than many other ra-
cial/ethnic groups (5).
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Hospitalizations are an important area of focus in diabetes care be-
cause they account for a major portion of health care cost (6,7) and
are highly burdensome to individuals and families. Diabetes-re-
lated potentially preventable hospitalizations (D-RPH) are of par-
ticular concern and were the target of recent policy action (8,9).
Potentially preventable hospitalizations are defined by the Agency
for Healthcare Research and Quality (AHRQ) as hospitalizations
preventable with accessible and effective outpatient disease man-
agement (9).
Among Hawaiian residents aged 65 years or older, Native Hawaii-
ans and some Asian groups are significantly more likely to have
D-RPHs, even after considering the high diabetes prevalence rates
in these racial/ethnic groups (10). However, little is known about
the outcomes of these hospitalizations. The goal of this study was
to compare deaths and length of stay for D-RPH in Hawai‘i for
major Asian American and Pacific Islander subgroups and for
older (≥65y) whites with Medicare coverage. These 2 outcomes
were chosen because they are regularly used, can be compared
with findings from other locations, and are relevant to patients,
providers,  and  health  care  administrators  (11–14).  Death  is  a
measured outcome of primary importance (11), and length of stay
is a commonly reported indicator for hospitalizations. Longer hos-
pitalizations are more expensive, are burdensome to patients, and
can put  patients  at  greater  risk for hospital-associated adverse
events (12,13). Among older adults, length of stay is a particu-
larly important issue because many older patients experience func-
tional and cognitive declines during hospitalization (14).
Hawai‘i  provides  excellent  opportunities  to  research D-RPHs.
Hawai‘i has a large population of older adults (15), growing rates
of diabetes (16), and a diverse ethnic population. Almost 40% of
Hawai‘i’s  population  is  Asian  American  (primarily  Filipino,
Chinese,  and  Japanese),  and  approximately  10%  are  Native
Hawaiian or other Pacific Islanders (17). As such, hospital data in
Hawai‘i have unique details about Asian American and Pacific Is-
lander racial/ethnic groups not captured in state-level data in most
other locations, which allows for disaggregated data on heterogen-
eous Asian and Pacific Islander groups.
Methods
The Hawaii Health Information Corporation (HHIC) is an inde-
pendent, not-for-profit health care data organization that collects
and validates detailed inpatient discharge data at the patient level
from all hospitalizations by all insurers in the state. HHIC data in-
clude information on race/ethnicity of patients, insurer, age, sex,
and International Classification of Diseases – 9th Revision – Clin-
ical Modification (ICD-9) codes (18). Patients in long-term care or
psychiatric  hospitals  are  excluded.  HHIC data  are  used as  the
Hawai‘i hospital data source for the major national inpatient data-
base (19), an indication of their high quality. For our sample, we
considered nonpregnancy-related hospitalizations from December
2006 through December  2010,  of  Hawaiian residents  aged 65
years or older with Medicare as the primary payer (n = 144,253).
Hospitalizations were excluded if they lacked valid race/ethnicity
data (n = 2,706) or they did not report Japanese, Chinese, Native
Hawaiian,  Filipino,  or  white  as  their  racial/ethnic  group  (n  =
14,468). These 5 racial/ethnic groups are the major racial/ethnic
groups in Hawai‘i. After exclusions, there were a total of 127,079
eligible hospitalizations.
Sample
Following AHRQ definitions, we used ICD-9 discharge codes to
identify D-RPH (20). We included in our sample patients hospital-
ized with 1) uncontrolled diabetes without mention of a short-term
or long-term complication, 2) diabetes with short-term complica-
tions (eg, ketoacidosis, hyperosmolarity, coma), 3) diabetes with
long-term complications (eg, renal, eye, neurological, circulatory
complications;  complications  not  otherwise  specified),  and 4)
lower-extremity diabetes-related amputations. More detail is avail-
able from AHRQ (http://www.qualityindicators.ahrq.gov/Down-
loads/Modules/PQI/V31/pqi_guide_v31.pdf).  Although people
with a potentially preventable hospitalization for short-term or
long-term diabetes care may have had uncontrolled diabetes in the
past, there is no overlap by AHRQ definitions of preventable hos-
pitalizations for uncontrolled diabetes and potentially preventable
hospitalizations for short-term and long-term diabetes complica-
tions.
Variables
The HHIC race/ethnicity variable is created from the categories
available consistently across all hospitals in Hawai‘i from Decem-
ber 2006 to December 2010 (18). One primary race is reported
across all hospitals, typically from patient self-report at intake.
Mixed-race  individuals  are  represented  as  their  self-reported
primary race. The 5 included racial/ethnic groups were identified
consistently across all Hawai‘i hospitals during the study period.
The dependent variable, death during stay, was identified from the
hospital record’s discharge disposition as “expired.” Length of
stay was measured by the total number of days of each potentially
preventable hospitalization. We controlled for sex on the basis of
administrative data and for 3 age categories (65–74 y, 75–84 y,
and ≥85 y). We also controlled for comorbidities as measured by
the Charlson Comorbidity Index (CCI) (21). The CCI is a com-
monly used measure suitable for hospital discharge data that sums
the total 17 potential comorbidities (eg, heart failure, dementia,
lymphoma) weighted by severity into a single comorbidity score
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(21). A higher score indicates more comorbidity, which is associ-
ated with a greater likelihood of death and higher use of hospital
resources. Location of residence (lives on Oahu versus does not
live on Oahu) was also controlled.
Statistical analyses
Death during stay and length of stay were compared across Asian
American and Pacific Islander subgroups and whites in unadjus-
ted analyses and analyses were adjusted for age, sex, location of
residence, and comorbidity. After identifying patients across all
hospitals using the HHIC data, we included only 1 hospitalization
per patient for the analyses of in-hospital death. From these unique
patients, we compared the likelihood of in-hospital death during a
preventable hospitalization by race/ethnicity by using χ2  and a
multivariable logistic model.  Length of stay was compared by
race/ethnicity by using all hospitalizations rather than unique pa-
tients. A repeated measure, negative binomial regression model,
was used to address potential correlation within patients in these
analyses as these were not restricted to one hospitalization per pa-
tient.
Results
We found 1,700 D-RPHs during the study period by 1,424 unique
patients.  Significant differences were seen across racial/ethnic
groups for many clinical characteristics (Table 1).  D-RPHs by
Asian Americans and Pacific Islanders had significantly higher
percentages of female patients than D-RPHs by whites. The ma-
jority of patients lived on Oahu; this percentage ranged from 56%
for Native Hawaiians to 94% for Chinese. Notably, 59% of Nat-
ive  Hawaiians  with  a  D-RPH were  in  the  youngest  age group
(65–75 y), whereas only 6.3% were in the oldest age group (≥85
y). By contrast, 23.2% of Japanese patients were in the youngest
age group, and 32.4% of them were 85 years or older.
In unadjusted outcome variables, Native Hawaiians with a D-RPH
had the longest average lengths of stay, followed by whites and
Chinese. There were 53 deaths total in our study group. Seven per-
cent  of  D-RPH among Native Hawaiians ended in death com-
pared with 3.1% of D-RPHs among Japanese. D-RPHs by Native
Hawaiians also had the highest comorbidity scores, with the aver-
age CCI score 2 points higher than the CCI scores for Japanese D-
RPHs, 1.8 points higher than for Chinese D-RPHs, and 1.4 points
higher than for Filipino D-RPHs.
Multivariable models show predictions of length of stay and death
during stay by race/ethnicity after adjusting for comorbidity, age,
sex, and living on Oahu (Table 2). Compared with whites, Native
Hawaiians were significantly more likely to die during a D-RPH
(OR, 3.92; 95% CI, 1.42–10.87). Filipinos had significantly short-
er length of stay (RR, 0.77; 95% CI, 0.62–0.95) than whites. No
other racial/ethnic differences were significant in multivariable
models. In the model predicting in-hospital mortality, no control
factors were significant. In the model predicting longer length of
stay, other significant factors were being aged 64 to 74 years, be-
ing male, and having more comorbid conditions.
To provide insight into our study findings, we also considered the
frequencies of specific D-RPHs by racial/ethnic group (Figure).
The most common D-RPHs were long-term complications, fol-
lowed by amputations. Fewer D-RPHs were for short-term com-
plications and uncontrolled diabetes. Native Hawaiians, in particu-
lar,  had few D-RPHs for short-term complications and uncon-
trolled diabetes and high percentages for amputations.
Figure.  The  percentages  of  types  of  diabetes-related  preventable
hospitalizations in Hawai‘i from December 2006 through December 2010, by
racial/ethnic group. Data are from the Hawaii Health Information Corporation
(18). All comparisons by race/ethnicity within type are significant at P < .05.
 
Discussion
This statewide study found significant differences in the clinical
characteristics and outcomes of D-RPHs for Asian American and
Pacific Islander groups. Disparities were seen particularly for Nat-
ive Hawaiians, who were more likely to die during a D-RPH and
were hospitalized at younger ages for a D-RPH than other studied
racial/ethnic groups.  D-RPHs of  Native Hawaiians were more
likely to involve an amputation, which was the most expensive of
the 4 types of D-RPHs encountered in previous research (22).
A primary value of this research is to demonstrate the depth and
impact of diabetes-related disparities for Native Hawaiians. Previ-
ous studies have found that Native Hawaiians aged 65 years or
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older are not only diagnosed with diabetes at higher rates than oth-
er populations in Hawai‘i (23) but are also hospitalized at higher
rates for preventable diabetes-related conditions than whites, even
after adjusting for the higher diabetes prevalence in this popula-
tion (10).  Furthermore,  this study finds that  Native Hawaiians
covered by Medicare are more likely to die during these prevent-
able hospitalizations. This finding suggests that even after con-
trolling for comorbidity as we do in this study, Native Hawaiian
older adults are going to the hospital sicker than other studied ra-
cial/ethnic groups. Clinicians both inside and outside the hospital
should be aware of this disparity, because it suggests a greater ur-
gency for treatment in this population. Primary care clinicians may
need to refer older Native Hawaiian patients to treatment earlier
than patients in other racial/ethnic groups. Future research should
determine whether Native Hawaiians are sicker on admission to a
hospital than other racial/ethnic groups because  of delayed access
to care and devise innovative solutions (eg, greater use of peer
educators) (24,) to ensure that even vulnerable members of these
populations are receiving timely access to health care.
Our findings may also be useful for community health centers and
other organizations providing comprehensive, preventive services
to help underscore the importance of strong chronic disease care
management. Patients may also be interested in knowing of the ap-
parent inequity in Native Hawaiian deaths during D-RPHs to un-
derscore  the  importance  of  both  condition  management  and
promptly seeking treatment when an urgent condition (eg, sign of
infection) arises.
A previous study found that older Japanese, Filipino, and Chinese
adult populations were also more likely to be hospitalized for a D-
RPH (even considering the higher diabetes prevalence in these
groups) than older white adults (10). However, in this study, these
racial/ethnic groups did not have a greater likelihood of poorer D-
RPH hospitalization outcomes than whites. This suggests that for
older Asians, unlike for older Native Hawaiians, the disparities for
D-RPHs compared with whites end at the point of higher rates of
these hospitalizations. Native Hawaiians, however, are more likely
to die during a D-RPH. This finding provides a better portrait of
the issues and disparities for diabetes-related outcomes among
older Asian and Native Hawaiian populations. Better understand-
ing of the patterns of D-RPHs can guide more focused interven-
tions for understudied groups of patients.
Our findings of health care disparities among Native Hawaiian D-
RPHs are of interest because our study focuses on residents of
Hawai‘i covered by Medicare. A uniform payer, such as Medicare,
could potentially reduce disparities in outcomes. Other evidence
suggests that even as a uniform payer, Medicare does not resolve
disparities between Asian Americans and Pacific Islanders and
whites in quality of care (5). For instance, 1 study showed that
Asian Medicare beneficiaries had longer waits to see a doctor and
were less likely to receive diabetes-related eye examinations or be
tested for hemoglobin A1c, lipid levels, and microalbuminuria, or
to receive self-care instruction (5). Yet Medicare, which begins
coverage at age 65 or at the point of disability, cannot fully re-
solve disparities that arise from many years of poorly controlled
diabetes before a person becomes eligible for Medicare. Ideally,
the poor diabetes-related outcomes seen in this study, particularly
among Native Hawaiians, could be resolved by preventing, or bet-
ter controlling, diabetes at young ages. For this reason, our study
findings should be of interest to Medicaid and to private insurers
who are the primary payers of working-age people. This study also
underscores the importance of existing, innovative programs seek-
ing to reduce diabetes prevalence across diverse Asian American
and Pacific Islander groups, including the PILI ‘Ohana Project
(25) and the Diabetes Detection and Prevention Project (26).
We did not find significantly longer lengths of stay for D-RPHs
among Asian and Pacific Islander groups than among whites. In-
stead, we that found Filipinos had significantly shorter lengths of
stay for D-RPHs. Longer lengths of stay may signify more com-
plications or greater danger for hospital-associated adverse events.
On the other hand, shorter lengths of stay may be associated with
more adverse events following discharge (13). This would be an
informative area of research among Filipinos. Another area for fu-
ture research is determining whether the shorter length of diabetes-
related hospital stays among Filipinos is due to less severe illness,
distinct comorbidities compared to other racial/ethnic groups, or
other factors. The CCI factors evaluated in this study did not in-
dicate that Filipinos had fewer comorbidities than other racial/eth-
nic groups.
We also found differences in clinical characteristics across groups
that  could inform the design and focus of  interventions.  Even
among an older population, Native Hawaiians experienced a D-
RPH at  a  younger  age than other  racial/ethnic  groups studied.
These findings are consistent with previous research (10) and are
particularly troubling because they are coupled with the greater
likelihood that Native Hawaiians will die during preventable hos-
pitalizations.
Although this study has numerous strengths, including 4 years of
data from a large, statewide sample and representation of diverse
Asian American and Pacific Islander groups, the study has some
limitations.  These  data  do  not  provide  information  on  many
factors that might be useful to explain or better understand health
disparities among racial/ethnic groups, particularly some clinical
factors such as depression and social determinants such as famili-
al support. We were unable to consider factors such as obesity,
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time since  diagnosis,  education,  or  proximity  to  primary  care
(27–29). We were also unable to include other Pacific Islanders
(eg, Samoans, Tongans, Micronesians), either generally or as spe-
cific subgroups, in our analyses because the sample sizes of these
groups were too small to perform comparative, multivariate ana-
lyses. These areas require further study, especially given that oth-
er Pacific Islanders have known health disparities in diabetes and
are extremely understudied (30,31). Another limitation is that pos-
sible differences in coding across hospitals may have affected our
analysis (32). Findings may also reflect preferences for the loca-
tion of end-of-life care or differences in access to information
about options for end-of-life care. Some racial/ethnic groups may
be more likely to be transferred to hospice than others. It is also
possible that the relatively small number of deaths during a D-
RPH may have affected our ability to find significant differences
in this outcome.
Efforts of the Centers for Medicare and Medicaid Services to ad-
dress disparities have not traditionally focused on Asian Americ-
ans and Pacific Islanders (5). Yet estimates suggest that by 2050,
approximately 1 of every 10 Americans, approximately 38 mil-
lion, will be of Asian or Pacific Islander descent (4). Evidence
from this study suggests that Medicare should pay particular atten-
tion to disparities among older Native Hawaiians, because mem-
bers of this group were more likely to die during a D-RPH than
older white adults and were more likely to experience a D-RPH at
a younger age than other racial/ethnic groups studied. Focused in-
terventions are needed that target Native Hawaiians to avoid these
outcomes. Further study is also needed to determine how the mix
of diagnoses and heavier burden of comorbidities might contrib-
ute to the higher in-hospital mortality rate for this population.
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Tables
Table 1. Demographic Characteristics of Medicare Recipients Aged 65 Years or Older (n = 1,424) With Diabetes-Related
Preventable Hospitalizations (n = 1,700), Hawai‘i, December 2006–December 2010
Characteristic Chinese Filipino
Native
Hawaiian Japanese White P Valuea
Number of patients 98 282 254 518 272 NA
Number of hospitalizations 116 341 308 599 336 NA
Hospitalizations per patient, mean (SD) 1.18 (0.48) 1.21 (0.55) 1.21 (0.55) 1.16 (0.50) 1.23 (0.61) .35
Age at last diabetes-related preventable hospitalization, y, n (%)
65–74 22 (22.5) 101 (35.8) 151 (59.4) 120 (23.2) 127 (46.7) <.001
75–84 51 (52.0) 139 (49.3) 87 (34.2) 230 (44.4) 101 (37.1) <.001
≥85 25 (25.5) 42 (14.9) 16 (6.3) 168 (32.4) 44 (16.2) <.001
Female 48 (49.0) 164 (58.4) 140 (55.1) 267 (51.4) 118 (43.2) .007
Living on Oahu 92 (93.9) 216 (76.6) 141 (55.5) 409 (79.0) 162 (60.0) <.001
Expired —b —b 18 (7.1) 16 (3.1) —b .017
Length of stay (days), mean (SD) 9.1 (11.1) 7.4 (8.8) 10.9 (16.8) 8.6 (11.9) 10.2 (14.1) .015
Charlson Comorbidity Index, mean (SD) 4.8 (3.1) 5.0 (3.2) 6.4 (3.6) 4.4 (3.1) 5.4 (3.1) <.001
Abbreviation: SD, standard deviation; NA, not applicable.
a The P value for “expired” for race/ethnicity was derived by using a χ2 analysis. The P value for length of stay by race/ethnicity was derived by using an
analysis of variance.
b The value of this cell is less than 10 and cannot be presented because of data privacy rules regarding number of patients less than 10.
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Table 2. Results From Multivariable Models Predicting Length of Stay and Death Among Medicare Patients Aged 65 years
or Older (n = 1,424) With a Diabetes-Related Preventable Hospitalization (n = 1,700), Hawai‘i, December 2006–Decem-
ber 2010a
Demographic Characteristic Deaths, Odds Ratio (95% CI) Length of Stay, Relative Risk (95% CI)
Race/ethnicity
Chinese 2.71 (0.75–9.81) 0.90 (0.69–1.17)
Filipino 1.76 (0.58–5.38) 0.77 (0.62–0.95)
Native Hawaiian 3.92 (1.42–10.87) 0.96 (0.75–1.22)
Japanese 1.69 (0.60–4.76) 0.90 (0.74–1.09)
White Reference Reference
Age
65–74 0.86 (0.39–1.92) 1.20 (1.01–1.42)
75–84 0.74 (0.34–1.60) 1.11 (0.94–1.32)
≥85 Reference Reference
Female versus male 0.96 (0.55–1.69) 0.81 (0.70–0.93)
Living on Oahu (yes vs no) 1.40 (0.72–2.72) 1.05 (0.89–1.23)
Charlson Comorbidity Index (1 unit
increase)
1.07 (0.98–1.16) 1.10 (1.08–1.11)
Abbreviation: HHIC, Hawaii Health Information Corporation; CI, confidence interval.
a Taken from Hawaii Health Information Corporation data (18).
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